A Study of Baricitinib and Probenecid in Healthy Participants

NCT01937026 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Baricitinib
DRUG: Probenecid

Sponsor

Eli Lilly and Company